From the Halifax Chronicle Herald:
Health Canada has given pharmaceutical giant GlaxoSmithKline permission to market its flu drug Relenza for the prevention of influenza, not merely the treatment of the illness.
The Canadian approval, announced by GSK on Thursday, follows in the footsteps of similar approvals by regulators in the United States and 15 European Union countries.
Other flu drugs on the market here — Tamiflu and the generic drug amantadine — were already approved for prevention of influenza. ...more
Saturday, January 06, 2007
Flu drug Relenza gets approval from Health Canada
The headline sounds bigger than the actual news. Relenza now has the official indication for prevention of influenza.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment